Fsgslumina.com has Server used IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2018-11-30 (1 year, 13 days) and hosted in Provo United States, server ping response time 108 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Fsgslumina keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Fs luminaires
2 Glumina
3 Gluminarel nephritis

Hosting Provider

Website: Fsgslumina.com
Hostname: box5637.bluehost.com
Region: UT
City: Provo
Postal Code: 84606
Latitude: 40.218101501465
Longitude: -111.61329650879
Area Code: 801
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain

New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   Hepworthsfreezerwear.com (1 seconds ago)

   Dlsu-aki.com (12 seconds ago)

   Hahavip.com (5 seconds ago)

   Hometesterclub.com (2 seconds ago)

   Pesosaludablesindietas.com (0 seconds ago)

   Ctfc.com (9 seconds ago)

   Drenajesostenible.com (1 seconds ago)

   Holzherasia.com (10 seconds ago)

   Goodnightnurse.com (3 seconds ago)

   Handsonchildrensmuseumjax.com (14 seconds ago)

   Cottonpickincupboards.com (0 seconds ago)

   Yougotthisretirement.com (11 seconds ago)

   Jeanpigozzi.com (6 seconds ago)

   Fsgslumina.com (0 seconds ago)

   Lkdesignstudio.com (35 seconds ago)

   Pearlmotoryacht.net (32 seconds ago)

   Kaxkar.com (10 seconds ago)

   Serenitywestrecording.com (6 seconds ago)

   Salmoneye.net (44 seconds ago)

   Bluevalleyrealty.com (26 seconds ago)

Results For Websites Listing

Found 43 Websites with content related to this domain, It is result after search with search engine

Lumina Study

FSGS is a rare disease that attacks the kidney's filtering units (glomeruli), causing serious scarring which leads to permanent kidney damage and even failure.


Lumina Study | FAQs - fsgslumina.com

If you complete the survey and your answers indicate you may be eligible, and you provide your email address, we will forward your contact to the study team at a trial site in your area.


Chronic Kidney Disease – ChemoCentryx

For more information, please visit www.fsgslumina.com. Diabetic Nephropathy ; Diabetic nephropathy is a form of chronic kidney disease, characterized by the gradual loss of kidney function. It is most common among people with Type 2 diabetes and hypertension and affects 26 million American adults.


ChemoCentryx And Aurinia In Focal Segmental

CCX140 is a CCR2 chemokine receptor antagonist in two Phase 2 clinical trials for sub-nephrotic primary FSGS (LUMINA-1) and nephrotic syndrome primary FSGS (LUMINA-2). Focal Segmental


AUPH / Aurinia Pharmaceuticals Inc - Institutional

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has 75 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).


NASDAQ:AUPH / Aurinia Pharmaceuticals Inc - Short Interest

AUPH / Aurinia Pharmaceuticals Inc short volume is shown in the following chart. Short Volume is a data set that can be used to understand investor sentiment. When an investor makes a short sale, they do so with the belief that a security will decline in price.


Black Diamond Labs - Home | Facebook

Black Diamond Labs, New York, New York. 4 likes. Black Diamond Labs is a NYC based tech company specializing in web/app design and digital advertising.


NephCure Kidney International (@Nephcure) Instagram

Creating new treatments for IgAN, FSGS, and other protein-spilling kidney diseases hinges on clinical trial participation. Researchers must test the efficacy, safety and a range of other treatment factors to know what works.


Third Quarter 2019 - ir.chemocentryx.com

CCX140 in FSGS: LUMINA-1 and LUMINA-2 Trials Running in Parallel; Data in 2020 (Biopsy-proven primary FSGS & assess proteinuria levels) 0 12 26 Study Assessments –Reduction in Proteinuria from Baseline (weeks) LUMINA-2 Enrolling CCX140, Dose escalation from 5 mg QD to 15 mg BID (n=6 to 13) Trial 1: Nephrotic syndrome primary


Anabolic Steroids In Kosovo | Best Supplements for Mass

Steroid Dependent Nephrotic Syndrome Bagga CCX140 is a CCR2 chemokine receptor antagonist in two Phase 2 clinical trials for sub-nephrotic primary FSGS (LUMINA-1) and nephrotic syndrome primary FSGS (LUMINA. that inhibits CCR2 and blocks. Steroids Rugby Players Another rugby player in Britain has been suspended after testing positive for banned


Recently Analyzed Sites